Acuta Capital Partners’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Acuta Capital Partners’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-80,000	Closed	-$2.99M	–	86
2018 Q1	$2.99M	Buy	+80,000	New	+$3.36M	0.49%	29

Acuta Capital Partners's ARMO Position: Q2 2018 in Review

Acuta Capital Partners sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 80,000 shares — an estimated $2.99M sold.

Acuta Capital Partners first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $2.99M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Acuta Capital Partners reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Acuta Capital Partners sold 80,000 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $2.99M.
Acuta Capital Partners first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Acuta Capital Partners's ARMO BioSciences, Inc. Common Stock position peaked at $2.99M in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Acuta Capital Partners's 13F filing for Q2 2018, filed 15 Aug 2018.